0001161697-24-000256.txt : 20240607 0001161697-24-000256.hdr.sgml : 20240607 20240607170008 ACCESSION NUMBER: 0001161697-24-000256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INGENITO GARY CENTRAL INDEX KEY: 0001279473 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 241030456 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 06-05-2024 X0508 4 2024-06-05 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001279473 INGENITO GARY 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Med. & Reg. Officer 0 Common stock, par value $0.001 per share 2024-06-05 4 M 0 80000 4.01 A 131391 D Common stock, par value $0.001 per share 2024-06-05 4 S 0 80000 16.16 D 51391 D Options to purchase common stock 4.01 2024-06-05 4 M 0 80000 0 D 2025-01-02 Common Stock 80000 1050575 D Dr. Ingenito sold the shares on the open market to for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.11 to $16.27 per share. Options vested in three annual tranches beginning on January 2, 2019. /s/ Gary Ingenito 2024-06-07